Skip to main content
. 2017 Apr 27;8:476. doi: 10.3389/fimmu.2017.00476

Table 2.

Comparison of serum concentrations of SIgA, total IgA, IgA anti-Chlamydia trachomatis antibodies, and IgA anti-Shigella spp. antibodies between patients and controls.

Variable Controls (n = 53) Patients
Total, n = 46 (p value) HLA-B27+, n = 22 (p value) HLA-B27, n = 24 (p value) >12 m, n = 24 (p value) ≤12 m, n = 22 (p value)
SIgA (g/ml)
Mean ± SD 10.8 ± 6.5 19.8 ± 9.9 (<0.001)a, 19.5 ± 11.5 (0.0001)a, 20.1 ± 8.6 (<0.001)a, 22.9 ± 10.7 (0.001)a, 16.7 ± 8.2 (0.0015)a,
Total IgA (mg/dl)
Mean ± SD 284 ± 107 275 ± 123 (0.72)a 299 ± 140 (0.62)a 255 ± 106 (0.27)a 292.7 ± 132 (0.76)a 257.9 ± 115 (0.349)a
IgA anti-C. trachomatis (ratio)
Median [min–max] 0.44 [0.15–1.75] 0.55 [0.12–13.03] (0.06)b 0.46 [0.12–13.03] 0.59 [0.29–10.4] 0.67 [0.11–3.57] 0.45 [0.17–13.0]
IgA anti-Shigella spp. (titers)
Median [min–max] 1/800 [1/200–1/6,400] 1/800 [1/200–1/6,400] (0.12)b 1/400 [1/200–1/6,400] 1/800 [1/200–1/3,200] 800 [1/200–1/6,400] 800 [1/200–1/6,400]

aStudent’s t-test.

bMann–Whitney test.

Statistical significance, p < 0.05.

HLA-B27+, HLA-B27 allele positive; HLA-B27, HLA-B27 allele negative; SIgA, secretory immunoglobulin A; >12 m, more than 12 months from diagnosis; <12 m, less than 12 months from diagnosis.